🦊/Companies

Fifth Eye

6 known investors

Find your way into Fifth Eye

346 people in our graph share verified history with the Fifth Eye team — schools, employers, funds. One of them is your warm intro.

William Schmidtunlockedknows Jen Baird, NACD.DC · together at Fifth Eye Inc. (overlapped)
knows the team · via SeaStar Medical
×4knows the team · via University of Michigan Medical School
knows the team · via Lawrence Technological University
×4knows the team · via University of Michigan Center for Integrative Research in Critical Care
knows the team · via Airstrip

Software that detects subtle vital-sign changes to warn medical professionals of post-operative patient deterioration risk.

Founders & leadership

JBJen Baird, NACD.DC
Jen Baird, NACD.DCFounderJen Baird is an NACD-certified board director with over two decades of experience founding and leading venture-backed startups as CEO, including companies that achieved FDA clearances and successful clinical deployments in healthcare technology. She currently serves on public, private, and non-profit boards and is active as a mentor and angel investor.
MSMark Salamango
Mark SalamangoFounderMark Salamango has worked for over 20 years in technology, strategy, and management roles, with experience in software architecture and government business development. He is founder of Fifth Eye, which develops software to detect vital-sign changes and alert medical professionals to post-operative patient deterioration risk.

Investors · 6

Also in the syndicate · 2

Biosciences Research and Commercialization CenterMINTS

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Fifth Eye do?
Software that detects subtle vital-sign changes to warn medical professionals of post-operative patient deterioration risk.
Who founded Fifth Eye?
Fifth Eye was founded by Jen Baird, NACD.DC, Mark Salamango.
Who are Fifth Eye's investors?
Fifth Eye's investors include Invest Michigan, WMU Biosciences Research & Commercialization Center, Arboretum Ventures, Cultivation Capital.